184 related articles for article (PubMed ID: 30860040)
1. US lawmakers seek cuts in prescription drug prices.
Jaffe S
Lancet; 2019 Mar; 393(10175):975-976. PubMed ID: 30860040
[No Abstract] [Full Text] [Related]
2. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
Sarpatwari A; Avorn J; Kesselheim AS
JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
[No Abstract] [Full Text] [Related]
3. The Burden of Federalism: Challenges to State Attempts at Controlling Prescription Drug Costs.
Gudiksen KL; King JS
J Leg Med; 2019; 39(2):95-120. PubMed ID: 31503534
[No Abstract] [Full Text] [Related]
4. McKesson settling up. $190 million payment latest in drug-price flap.
Carlson J
Mod Healthc; 2012 Apr; 42(18):14. PubMed ID: 22667036
[No Abstract] [Full Text] [Related]
5. Rx: higher prices.
Kosterlitz J
Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
[TBL] [Abstract][Full Text] [Related]
6. Prescription-drug prices.
Frank RG
N Engl J Med; 2004 Sep; 351(14):1375-7. PubMed ID: 15459294
[No Abstract] [Full Text] [Related]
7. Positive signals from Washington.
Fox JL
Nat Biotechnol; 2012 Apr; 30(4):306-8. PubMed ID: 22491273
[No Abstract] [Full Text] [Related]
8. Remember the MaineRx.
Kemp R
Appl Health Econ Health Policy; 2014 Feb; 12(1):1-5. PubMed ID: 24420789
[TBL] [Abstract][Full Text] [Related]
9. Opinion: price controls on prescription drugs.
Franks B
N J Med; 2004 Apr; 101(4):56, 55. PubMed ID: 15103791
[No Abstract] [Full Text] [Related]
10. Prescription drug prices in the US.
Med Lett Drugs Ther; 2017 May; 59(1521):81-83. PubMed ID: 28520697
[No Abstract] [Full Text] [Related]
11. States sue generic drug makers for alleged price fixing.
McCarthy M
BMJ; 2016 Dec; 355():i6764. PubMed ID: 27993771
[No Abstract] [Full Text] [Related]
12. Perspectives. Fences loom for free-ranging drug prices.
Kent C
Faulkner Grays Med Health; 1991 Oct; 45(39):suppl 4 p. PubMed ID: 10113759
[No Abstract] [Full Text] [Related]
13. Paying for Prescription Drugs in the New Administration.
Kesselheim AS; Hwang TJ; Avorn J
JAMA; 2021 Mar; 325(9):819-820. PubMed ID: 33651097
[No Abstract] [Full Text] [Related]
14. The Price of Crossing the Border for Medications.
Fralick M; Avorn J; Kesselheim AS
N Engl J Med; 2017 Jul; 377(4):311-313. PubMed ID: 28745989
[No Abstract] [Full Text] [Related]
15. Value-Based Pricing and Patient Access for Specialty Drugs.
Robinson JC; Howell S; Pearson SD
JAMA; 2018 Jun; 319(21):2169-2170. PubMed ID: 29801023
[No Abstract] [Full Text] [Related]
16. Can price and regulatory controls replace free market competition in the drug industry?
Buc NL; Levitt GM
Healthspan; 1993 Nov; 10(10):30-2. PubMed ID: 10130839
[No Abstract] [Full Text] [Related]
17. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
American Society of Clinical Oncology
J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877
[No Abstract] [Full Text] [Related]
18. American pharmaceutical prices.
Alagona P
Pharos Alpha Omega Alpha Honor Med Soc; 2002; 65(4):58. PubMed ID: 12592980
[No Abstract] [Full Text] [Related]
19. Value-Based Pricing for Drugs: Theme and Variations.
Kaltenboeck A; Bach PB
JAMA; 2018 Jun; 319(21):2165-2166. PubMed ID: 29710320
[No Abstract] [Full Text] [Related]
20. PhRMA sues on 340B orphans.
Lee J
Mod Healthc; 2013 Oct; 43(40):17. PubMed ID: 24340726
[No Abstract] [Full Text] [Related]
[Next] [New Search]
